Please ensure Javascript is enabled for purposes of website accessibility

What’s Behind California’s Frozen Housing Market?

10 hours ago

Oil Prices Rise on Trade War Relief, US Pressure on Russia

11 hours ago

Marjorie Taylor Greene Is First Republican Lawmaker to Call Gaza Crisis a ‘Genocide’

13 hours ago

UK Will Recognize Palestinian Statehood in September, Barring Israel-Hamas Ceasefire

13 hours ago

Trump’s EPA to Repeal Core of Greenhouse Gas Rules in Major Deregulatory Move

14 hours ago

US Approval of Israel’s Gaza Offensive Drops to 32%, Poll Shows

15 hours ago

Shooter in New York Skyscraper Left Note Blaming NFL for Brain Injury, Mayor Says

15 hours ago

Trump Eyes Aug 1 Trade Deals as EU, China Talks Continue, US Commerce Chief Says

15 hours ago

Trump Says Many Are Starving in Gaza, Vows to Set up Food Centers

2 days ago
Gilead Says Drug Helped Moderately Ill Coronavirus Patients
gvw_ap_news
By Associated Press
Published 5 years ago on
June 2, 2020

Share

A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.

Remdesivir is the only treatment that’s been shown in a rigorous experiment to help fight the coronavirus. A large study led by the National Institutes of Health recently found it could shorten average recovery time from 15 days to 11 days in hospitalized patients with severe disease.
Gilead Sciences gave few details on Monday but said full results would soon be published in a medical journal.
Remdesivir is the only treatment that’s been shown in a rigorous experiment to help fight the coronavirus. A large study led by the National Institutes of Health recently found it could shorten average recovery time from 15 days to 11 days in hospitalized patients with severe disease.
The drug is given through an IV and is designed to interfere with an enzyme the virus uses to copy its genetic material. It’s approved for treating COVID-19 in Japan and is authorized for emergency use in the United States for certain patients.
The company-led study involved nearly 600 patients who had moderate pneumonia but did not need oxygen support. All were randomly assigned to get five or 10 days of the drug plus standard care, or standard care alone. Patients and their doctors knew who was getting what, which limits the objectivity of the results.
By the 11th day in the study, those on five days of remdesivir were 65% more likely to improve by at least one on a seven-point scale that included measures such as needing treatment with a breathing machine, Gilead said.

There Were No Deaths Among Patients on Five Days of the Drug

Ten days of treatment did not prove better than standard care alone.
There were no deaths among patients on five days of the drug, two among those on 10 days, and four among patients getting standard care alone. Nausea and headache were a little more common among those on the drug.
The study has some limitations, but “there was a control group which does help verify that remdesivir has some benefits,” said Dr. Radha Rajasingham, an infectious disease specialist at the University of Minnesota Medical Center in Minneapolis who had no role in the work.
Since there are limited supplies of the experimental drug, finding benefit from five versus 10 days means more people can be treated, she added.
In a note to investors, Evercore ISI analyst Umer Raffat noted that the study’s main goal was changed partway through, from the percentage of patients discharged within two weeks to the scale of improvement after 11 days.
“A fair amount of critical data,” such as hospital discharge information, has not been disclosed, he wrote.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

California Under Tsunami Advisory After Magnitude 8.7 Earthquake

DON'T MISS

Fresno Man Dies in DUI Crash, Driver Arrested

DON'T MISS

Madera County Wildfire Burns Near Fairmead, Containment at 0%

DON'T MISS

Watch Twin Meteor Showers Reach Their Simultaneous Peak in Summer Skies

DON'T MISS

New York Gunman Was Flagged by Security Camera System Before Attack, Sources Say

DON'T MISS

As Trump Cuts Education, Candidates Line Up for California’s Top Schools Job

DON'T MISS

US House Panel Rejects Immunity Request by Epstein Associate Maxwell

DON'T MISS

Fresno’s Vacant Property Ordinance Punishes the Wrong People: Rassamni

DON'T MISS

Trump Approval Rating Sinks to 40%, the Lowest of His Term, Reuters/Ipsos Poll Finds

DON'T MISS

What’s Behind California’s Frozen Housing Market?

UP NEXT

New York Gunman Was Flagged by Security Camera System Before Attack, Sources Say

UP NEXT

US House Panel Rejects Immunity Request by Epstein Associate Maxwell

UP NEXT

Trump Approval Rating Sinks to 40%, the Lowest of His Term, Reuters/Ipsos Poll Finds

UP NEXT

Trump Says Wall Street Journal, Murdoch Want to Settle Defamation Lawsuit

UP NEXT

New York Officer Killed in Manhattan Shooting Remembered as Hero in Bangladesh, US

UP NEXT

US States Sue Over Trump Demands for Data on Food Stamp Recipients

UP NEXT

FAA Failed to Act Before Helicopter Crash, Transport Chief Says

UP NEXT

Marjorie Taylor Greene Is First Republican Lawmaker to Call Gaza Crisis a ‘Genocide’

UP NEXT

New Gallup Poll Reveals Most Immoral Behaviors In America

UP NEXT

Trump’s EPA to Repeal Core of Greenhouse Gas Rules in Major Deregulatory Move

Watch Twin Meteor Showers Reach Their Simultaneous Peak in Summer Skies

7 hours ago

New York Gunman Was Flagged by Security Camera System Before Attack, Sources Say

7 hours ago

As Trump Cuts Education, Candidates Line Up for California’s Top Schools Job

8 hours ago

US House Panel Rejects Immunity Request by Epstein Associate Maxwell

8 hours ago

Fresno’s Vacant Property Ordinance Punishes the Wrong People: Rassamni

9 hours ago

Trump Approval Rating Sinks to 40%, the Lowest of His Term, Reuters/Ipsos Poll Finds

9 hours ago

What’s Behind California’s Frozen Housing Market?

10 hours ago

Tulare County Authorities Find Body in Sequoia National Park

11 hours ago

Oil Prices Rise on Trade War Relief, US Pressure on Russia

11 hours ago

Scottie Scheffler vs. Everybody: Open Champion Makes His Case Among the Greats

11 hours ago

California Under Tsunami Advisory After Magnitude 8.7 Earthquake

Update at 7:35 p.m. on July 29 The U.S. National Weather Service has issued a tsunami advisory for the California coast, with projected arri...

6 hours ago

6 hours ago

California Under Tsunami Advisory After Magnitude 8.7 Earthquake

Juan Carlos Mendoza Jr., 23, was arrested on suspicion of DUI and vehicular manslaughter after a crash in Fresno County killed a 24-year-old passenger. (Fresno County SO)
6 hours ago

Fresno Man Dies in DUI Crash, Driver Arrested

A wildfire in Madera County, dubbed the 19 Fire, has burned 16 acres with 0% containment as of Tuesday, July 29, 2025, afternoon, according to CalFire. (CalFire)
6 hours ago

Madera County Wildfire Burns Near Fairmead, Containment at 0%

7 hours ago

Watch Twin Meteor Showers Reach Their Simultaneous Peak in Summer Skies

A man holding a rifle walks into an office building at 345 Park Avenue shortly before a shooting that killed several people, in the Midtown Manhattan district of New York City, U.S. July 28, 2025, in a still image taken from surveillance video. Surveillance Camera/Handout via REUTERS
7 hours ago

New York Gunman Was Flagged by Security Camera System Before Attack, Sources Say

Teacher Uses Globe While Instructing Her Students
8 hours ago

As Trump Cuts Education, Candidates Line Up for California’s Top Schools Job

Jeffrey Epstein associate Ghislaine Maxwell stands at the podium to address Judge Alison Nathan during her sentencing in a courtroom sketch in New York City, U.S. June 28, 2022. (Reuters File)
8 hours ago

US House Panel Rejects Immunity Request by Epstein Associate Maxwell

9 hours ago

Fresno’s Vacant Property Ordinance Punishes the Wrong People: Rassamni

Help continue the work that gets you the news that matters most.

Search

Send this to a friend